Foreign Investor Leads Class Action V. Drug Co.
By Ron Zapata ( January 9, 2008, 12:00 AM EST) -- A Luxemburg-based investment firm has been appointed lead plaintiff in a consolidated shareholder class action against anti-cancer drug maker GPC Biotech AG despite concerns over a foreign investor's rights in U.S. securities suits....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.